Maravai LifeSciences Holdings, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of MRVI for the last quarter is 74.14 M USD, and it's 10.88% higher compared to the previous quarter. The net income of Q4 23 is -105.96 M USD.